Maybe an even better use of shareholder funds would be to get the people who did the independent review to take over the running of this company.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025